CBL-0137 FREE BASE
Recurrent Diffuse Intrinsic Pontine Glioma
Children's Oncology GroupSmall moleculePhase 1/2Active
CC
44/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 29/ 100
- Competitive Position
- 95/ 100
Competitive context
27 Active assets in the Recurrent Diffuse Intrinsic Pontine Glioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan Actuate Therapeutics Inc. | Phase 2 | BB |
(+)-VINCRISTINE Julie Krystal | Phase 2 | B |
Valproic Acid University of Göttingen | Phase 3 | B |
Ribociclib Nationwide Children's Hospital | Phase 2 | B |
Cyclophosphamide Shenzhen Geno-Immune Medical Institute | Phase 2 | B |
View all 42 →
Same molecule, other indications
CBL-0137 FREE BASE is also rated in:
Metastatic Malignant Neoplasm in the Central Nervous SystemDormant
CC
Indicative ·
44 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →